TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program July 3, 1981
TCL Archive In Brief: Abeloff Directs John Hopkins Oncology Center; Claudia Baquet Named Deputy Secretary In HHS September 25, 1992
